Explore more publications!
Africa News Observer
Submit Press Release

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 3, 2025

EdTalkies Partners with KEPSHA to Champion AI-Powered Competency-Based Learning Across Kenya
November 3, 2025

EdTalkies Partners with KEPSHA to Champion AI-Powered Competency-Based Learning Across Kenya

Indeterminate EIN Presswire
The Growfessor LLC introduces ‘The Multiplier Effect,’ A Framework to Multiply Leadership Impact Across Teams
November 3, 2025

The Growfessor LLC introduces ‘The Multiplier Effect,’ A Framework to Multiply Leadership Impact Across Teams

Indeterminate EIN Presswire
ACASS-OPERATED FALCON 8X COMPLETES MAIDEN FLIGHT TO ANTARCTICA
November 3, 2025

ACASS-OPERATED FALCON 8X COMPLETES MAIDEN FLIGHT TO ANTARCTICA

Indeterminate EIN Presswire
Towing Industry Honors Fallen Tow Operators
November 3, 2025

Towing Industry Honors Fallen Tow Operators

Indeterminate EIN Presswire
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
November 3, 2025

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
128 Assets Ltd Appointed Agent Recruitment Partner for Cavalry Water Recycling EB-5 Project
November 3, 2025

128 Assets Ltd Appointed Agent Recruitment Partner for Cavalry Water Recycling EB-5 Project

Indeterminate EIN Presswire
ALPHAMIN ANNOUNCES CAD $0.04 PER SHARE SECOND INTERIM FY2025 DIVIDEND / FILES Q3 2025 FINANCIAL STATEMENTS AND MD&A
November 3, 2025

ALPHAMIN ANNOUNCES CAD $0.04 PER SHARE SECOND INTERIM FY2025 DIVIDEND / FILES Q3 2025 FINANCIAL STATEMENTS AND MD&A

Indeterminate GlobeNewswire
Granting of Incentive Stock Options
November 3, 2025

Granting of Incentive Stock Options

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
November 3, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

Indeterminate GlobeNewswire
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
November 3, 2025

Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025

Indeterminate GlobeNewswire
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
November 3, 2025

Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
PU Prime Launches Black Friday Copy Trading Campaign
November 3, 2025

PU Prime Launches Black Friday Copy Trading Campaign

Indeterminate EIN Presswire
Clinical Study Results on CercaTest RED™ Presented in 18th APCMFM
November 3, 2025

Clinical Study Results on CercaTest RED™ Presented in 18th APCMFM

Indeterminate EIN Presswire
Organogenesis Applauds CMS’s Significant Step In Payment Reform
November 3, 2025

Organogenesis Applauds CMS’s Significant Step In Payment Reform

Indeterminate GlobeNewswire
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 3, 2025

Cellectis to Present a Development Update for eti-cel at ASH 2025

Indeterminate GlobeNewswire
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
November 3, 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

Indeterminate GlobeNewswire
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
November 3, 2025

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

Indeterminate GlobeNewswire
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
November 3, 2025

Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions